secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001607062-21-000375
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clinigence receives $3M strategic equity investment from ApolloMed; issues shares and warrants
--------------------------------------------------------------------------------

- ApolloMed invests $3M; Clinigence issues 1M shares at $3.00 and warrants for 500k shares at $3.50.
- Brandon Sim (ApolloMed COO/CTO) appointed to board; director Elisa Luqman resigns, remains Secretary.
- Investment closed Sept 30, 2021; funding received Oct 1, 2021 – strengthens balance sheet for NASDAQ uplisting.
- ApolloMed will nominate one director; shares issued as private placement exempt from SEC registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000160706221000375/0001607062-21-000375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000160706221000375/clnh100121form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer